CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Comparative investigation of basal insulin glargine versus metformin treatment in drug naive type 2 diabetes patients: results of the GLORY study
DOI 10.1055/s-0032-1314592
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Pistrosch, F Schaper, C Köhler, W Landgraf, T Forst, T Behnke, M Sanuri, M Hanefeld
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Type 2 diabetes (T2D) is characterised by progressive loss of beta cell capacity with glucotoxicity as a booster. Current strategy with metformin (MET) as first line drug fails to prevent disease progression. Preliminary data indicate that early use of insulin in the course of the disease might be able to preserve beta cell function. We investigated whether basal insulin treatment in recently diagnosed T2D pat…
Zitieren
Zitierempfehlung
F Pistrosch, F Schaper, C Köhler, W Landgraf, T Forst, T Behnke, M Sanuri, M Hanefeld (2012) Comparative investigation of basal insulin glargine versus metformin treatment in drug naive type 2 diabetes patients: results of the GLORY study. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0032-1314592
Mit CareLit weiterarbeiten